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Rorterdam. The Ncthrrland.s 
Management of unstable angina has evdved progressively, 
mid coronary angh?plecty has rewntly been shown to be an 
e&ctlvc treatment strategy for unstable angina. However, 
the prodwe-related nmjor compllltlon rate is higher 
when compared with that for anglopbwty in staZ:; :@ZL 
The underlying pathophyslu@y may explain this higher 
co~pikatlon rite. Rupture uf an atheroselerutic plaque 
a3fadbd with thrumbus funnation is frequent in the 
p&ugen&dumtablesnglua.Tbeseprucessesleadtua 
crRtcd reductbn to myocardlal blood supply, aad coronary 
a@upl&y may eifectively interrupt this process. In cun- 
tmt, corowy aat#@&y itself may cause further injury 
d UK already ukemted intlma, have the patential to 
IoteNlfy the ougolng thNNbogesd* p- a@J lead to a” 
locreajed frequency of nbrupt closure of the artery during 
the procdwra. Therefore, bltrpeorrmary stre* was 
wed la the prmdure in those patients with abrcpt &sure 
d Use artery immediately after dilation to attempt to 
iNpNve the inulmuate Nsldt. 
death, the need fur emergency surgery ar evidence uf 
myucardiil necrusts. These benetkii results suggest hat, 
hssomecrwes,NNnaryMgloplprtynulyneedtobesup 
plemented by addltlunal intracaranary thrumbolysis to 
improve immediate uutcume by avoiding ur@nt surgery 
and prucedure4ated myucardll lafa~ctlun. 
(1 Am Coil Cardioll988;12:69A-77A) 
The clinical syndrome of unstable angina causes great con- 
cern to clinicians because of the perceived high risk of 
progression to myocardial infarction or cardiac death (1.2). 
Only limited information is available on the merits of phar- 
macoiogic treatment, coronary bypass surgery or coronary 
angioplasty from contrulled randomized trials in these pa- 
tients. Management of unstable angina has evolved despite 
this lack of trial data and, recently, coronary angioplasty was 
shown to be relatively safe and to result in significant 
symptomatic relief. However, the major complication rate 
(myocardial infarction. emergency bypass surgery and in- 
hospital mortality) is rather high when compared with that in 
patients with stable angina (3-S). In an early series (3) of 200 
patients with unstable angina, we reported that coronary 
angioplasty could be performed with a high initial success 
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rate (89.5%) but at an increased risk of major procedtire- 
related complications (lO.S%). The reasons for this relatively 
high complication rate are apparently related IO the under- 
lying patbophysioiogy ieading to the clmical instability and 
an increased risk of abrupt closure after attempted angio- 
plasty as a result of the formation of an acute occlusive 
thrombus (6.7). The present study was, therefore. under- 
taken to investigate whether additional thrombolytic therapy 
in instances of abrupt vessel closure could improve the 
immediate results of coronary angioplasty in patients with 
unstable angina pectoris. 
Methods 
Study patients. Between January 1986 and December 
1987, coronary angioplasty was attempted in 200 consecu- 
tive patients with unstable angina pectoris (Table I). They 
represented 20% of our total number of patients undergoing 
coronary angioplasty during the study period. All were 
treated intensively with a beta-adrenergic blocking agent, a 
Q1988 by the American College of Cnrdml~gy 0735lo!n/8863.M 
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T&k I. Clinical and Angiographic Characteristics of 200 Patients 
With Uns~ahle Angina 
As (mcdran) (yr) 59 (range 29 to 83) 
Men ,no., 148 (74%) 
Time trot8 angiography to PKA (median) tdsys) 2 ( range 0 lo 75)  
Foslinfarction unstable angina ho.) 94 (47%) 
Previous CABGIT’TCA (no.1 39 (20%) 
Single vessel disease (no )  120 w%) 
Doubk vessel dnease (no.) 56 (28%) 
Tripk vessei disease (no.) 24 (12%) 
Single vessel dilation k~.) I80 @8%) 
Mullivesxl dilation trio.) 20 (10%) 
AnBiogrsphic evidence 01 intracoronary thmmbus (no.) 43 (22%) 
CABG = coronary artery bypass su@.eiy: no. = number of palients: 
II-CA = coronary angioplasty. 
calcium ankgonis:, intravenous nitroglycerin and heparin. 
Patients were selected for attgioplasty if the ischemia-related 
coronary lesion was suitable for dilation. The stenotic artery 
was considered to be isehemia related in patients with single 
vessel disease, whereas in patients with multivessel disease, 
the ischemia-related artery was determined by correlation 
with documented rest ST segment changes on the electro- 
cardiogram (KG). as described previously (3). 
Unstable angina pectoris was defined as symptoms of 
angina at rest lasting for at least I5 min and associated with 
ST-T changes without evidence of further myocardial necro- 
sis, as defined by either cardiac enzyme elevation (crcatine 
kinase twice the normal value) or development of new 
pathologic Q waves. Intracoronary thrombus was defined as 
a definite contrast filling defect or contrast staining during 
angiography in at least two orthogonal views observed by at 
least two angiographers. In addition, patients with an isch- 
emia-related occluded vessel were considered to have 
thrombus. 
&oronary angtoplasty. This procedure was performed 
with prefotmed guiding catheters, steerable dilating balloon 
catheters and a pneumatic inflation device. A 7F pacing 
electrode catheter was positioned in the right atrium. Before 
the prccedure, 10,000 U of heparin and 250 mg of aspirin 
were administered intravenously. Two ECG leads and aortic 
pressure were monitored continuously. Initially balloon in- 
flation pressure was 2 atm, with subsequent inflatiaus rang- 
ing up to I2 atm. All procedures were carried out with a 
cardiac surgical team on standby. The current study differ8 
from the previous one (3) in regard to the management of 
complications during angioplasty. In case of abrupt vessel 
closure after angioplasty, emergency recanalization was 
attempted by repeat dilation with use of the same or a larger 
sized balloon. If this approach failed, immediate surgery was 
performed in those patients with major coronary dissection, 
whereas intracoronary streptokinase was given to those 
patients in whom abrupt occlusion was presumably due to 
acute thrombosis (Fig. I). After the procedure, all patients 
were followed up for 24 h in the coronatry care unit, where 
the ECG and cardiac enzyme levels were monitored. A 
peri-interventional myocardial infarction was diagnosed if 
either new pathologic Q waves developed or an abnormal 
cardiac enzyme elevation was documented. 
Angioplasry was considered successful when a reduction 
in the severity of the obstruction to <SO% luminal diameter 
narrowing was achieved with the abolition of acute ischemic 
symptoms and without progression to myocardial infarction, 
emergency surgery or death. Only the ischemia-related 
vessel was dilated in the majority (60 of 80) of the patients 
with multivessel disease. The clinical and angiographic char- 
acteristics arc shown in Table I. 
Results 
In the 200 patients who underwent coronary angioplasty 
for unstable angina pcctoris, 221 lesions were dilated (115 in 
the left anterior descending, 49 in the left circumflex and 48 
in the right coronary rrtery and 9 in a bypass graft). Single 
vessel dilation was performed in 180 patients, including 25 
multilesion dilations in the same artery. Double artery dila- 
tion was performed in 19 patients, and triple artery dilation 
in I. 
IntNcoNmuy streptakIna8e In abNpt eIosure after mglo- 
pIaNy. Technical failure to cross the lesion occurred in four 
patients whose &hernia-related artery was found to be 
occluded at the time of attempted angioplasty; three of these 
underwent elective coronary bypass surgery and one was 
treated conservatively. The obstructed artery was crossed 
and dilated in I% patients; however, an abrupt closure 
immediately after attempted dilation occurred in 21 (11%) of 
these patients. Closure was presumably due to occlusive 
thrombus in 12 patients who were treated with 250,000 U of 
intracoronary streptokinase, and successful dilation was 
achieved in 9 of these patients without evidence of further 
necrosis or the need for emergency surgery. Major coronary 
dissection was observed in four patients who underwent 
emergency bypa8s surgery. of the remaining five patients, in 
whom the mechanism of abrupt occlusion was uncertain, 
four had successful redilation with use of a larger sized 
balloon and one was treated conservatively (Table 2). In 
these 21 patients with abrupt closure after attempted angio- 
plasty, I2 had angiographic evidence of intracoronary 
thrombus before angioplasty. 
Peri-interventional myocardial inJarction, dellned by ei- 
ther cardiac enzyme elevation or new Q waves, was docu- 
mented in six patients, of whom four underwent emergency 
bypass surgery, with one death postoperatively (Table 2). 
Thus, among these 200 patients who underwent coronary 
angioplasty for unstable angina, final success in dilating the 
obstructed artery was achieved in I88 patients (209 lesions) 
without death, evidence of myoeardial necrosis or the need 
for emergency surgery. 
Figure I. Sequential angiograms of the right coronary artery in left 
anterior oblique projection. A, Before angioplasty; 8, immediately 
after angiopldsly; C, reocclusion 10 min after angioplasly; D, after 
redilation: and E. after irmacoronary slreplokinase and reditation. 
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Table 2. Management and Outcome of 21 Palients With Acute 
Vessel Clncure During Coronary Angioplasly 
” MI 
Redilation* 4 0 
IC SK t redilation 10 I 
IC SK + acute sumtry L I 
Emergency surgery 4 3t 
Conservative treatmenl I  I  
TOM 21 6 
‘Prolonged inflations w.th larger size balloon: tone patient died poslop- 
eralively. I C  = inlracoronary; MI = myocardial nfarclion: SK = sueptoki- 
“ax. 
- - .  
No. of X!k!!l5 
Men (no.) 
&.e (Yrl 
Previous infarclion (%*o) 
Multivessel disease (%) 
Multivessel drlations t%) 
Intracoronary ltrrombus t%r 
Abrupt vessel closure (%I 
Initial success rate t%) 
Major ca~plialions ( I ) *  
Death (%) 
Myocardi.4 infarction (%I 
Emergency surgery t%) 
F’revious Data (3) 
200 
82 
56 
37 
33 
0 
I5 
11.5 
89.5 
IO.5 
0.5 
8 
9 
Present Data 
206 
14 
50 
47 
‘lo 
IO 
22 
IO.5 
94 
4 
0.5 
3 
3 
‘Eitherdealh. myocardial nfarction or emergency surgery. Thrombolytic 
therapy had not heen used in our previous reported study (3). no. = percent 
of padents. 
infarction and emergency surgery) is rather high compared 
with elective coronary angioplasty, ranging from 8 to 13% 
(3,8-23), although Meyer et al. (13) reported a lower com- 
plication rate. 
Reasons for higher complkalion rate for mtgioptasty in 
unstable angina. The reasons for this high complication rate 
are apparently related to the underlying pathophysiology. 
Almost all patients with unstable angina pectoris have a high 
grade fixed coronary stenosis (24,25), and in addition to this 
fixed stenosis, other dynamic conditions may also play a 
role, such as plaque fissuring with platelet aggregation, 
increased vasomotor tone and formation of a partial or even 
intermittent occlusive thrombus (26-30). Evidence derived 
from postmortem pathologic studies (29,30), postmortem 
coronary arteriography (30, serial coronary arteriography 
(25,32,33), lysis of intracoronary thrombi (34). surgery dur- 
ing acute coronary syndromes (35) and intraoperative angio- 
scopy (36) has confirmed the importance of coronary throm- 
bosis as a factor in unstable angina. Further clinical evidence 
(28,37-l2) to support the role of intracoronary thrombus 
comes from the observation that thrombolytic therapy in 
patients with unstable angina did lyse the thrombus in a 
considerable number of patients (Table 5). The role of 
platelets in intracoronary thrombus is also shown by the 
reduction in the incidence of death and nonfatal myocardial 
infarction after the administration of aspirin to patients with 
unstable angina (4344). 
Angiographk identilkation of intracoronary throntbus. 
The formation of an intracoronary thrombus is an active 
dynamic process. Identification of such a thrombus with 
angiography depends on the timing of the angiogram after 
the acute event, the size of the intracoronary thrombus at the 
time of the angiogram, the severity of illness in the patient 
studied and the angiographic criteria used for identiiication 
(28.45-48). The angiographic presence of an intracoronaty 
thrombus in unstable angina is reported to be between 1 and 
52% (Table 6). Angiographic criteria probably underestimate 
the frequency of thrombosis in patients with unstable angina 
pectoris because a mural (nonocclusive) thrombus superim- 
posed on an atherosclerotic plaque cannot always be identi- 
fied wi!h currently available techniques. In a pilot study (36) 
using intraoperative angio.copy, an intracoronary thrombus 
that was undetectable on review of the coronary angiograms 
was detected in 7 of 10 patients with unstable angina. 
Unstable angina and non-Q wave infarction. Several stud- 
ies (29,30,4%52) have emphasized the important pathophys- 
iologic link between unstable angina and non-Q wave myo- 
cardial infarction. In unstable angina, the pathophysiologic 
process is limited to endothelial ulceration, platelet aggrega- 
tion and thrombus formation, which may be intermittent or 
more permanent in the presence of an adequate collateral 
blood supply. Myocardial infarction is related to !he same 
process, but with the formation of a totally occlusive throm- 
bus. When the balance between intracoronary thrombus and 
I A C C  Vol. 12, No. 6 S U R Y A P R A P I A T A  ET AL. 73A 
December 198R:69A-17A THROMBOLYIIS D U R I N G  AN(; lOPLASTY FOR UNSTABLE A N G I N A  
Table 4. Reported Retults of Coronary Angioplacty for Unqrable Angina (ovllally ?tabdi,ed. refractory or  early poqlinfarclion) 
Coronary Events After 
Study (reDiYear 
No of 
Rs 
Faxon et al. (lNl983t 
Quigley ct al. (910986 
de Feyter et al. (IO)/1987 
Sleffenino et al. (II)11987 
442 
2s 
71 
89 
63 
XI 
87 
90 
09 8 -  
4 12 I2 
0 III I2 
0 5 5 
Refmcrory Umrahle Angma 
1.7 15 18 18 
0 0 32 18 
2 2 23 I2 
0 1.5 23 IO 
Williams er  al. (12)*/1981 
Meyer et al. ( i3)11983 
de Feyter e; ..I. (L4111985 
Timmis et al. (15)/B&7 
Plokker et al. (16)/1988 
Sharma cl al. (17)/19&l 
17 76 0 0 6 0 0 8 IO.5 
SO 74 0 4 2 0 0 36 6 
60 93 0 7 7 2 0 13 9 
56 7”  5.4 71 I2 5 3.3 3.3 39 6 
469 na I 49 3 I.5 0.1 ?I 19.3 
40 88 0 0 I2 0 0 34 II 
Early Postmfarctton Unstable Angma (5 30 days after Ml) 
de Feyter et al. (IS)/1986 53 89 0 8 8 0 4 26 9 
HOll et al. (19)/1986 69 80 2 -  I? 0 4 24 21 
Gotlieb et al. (20)/1987 47 91 2 4 I 3  3 18 16.3 
Saliant cl al. (21)/1987 68 87 0 1.5 1.5 0 2 41 17 
Sa?,q?Tmata CI al. (22)w88 60 85 0 5 7 0 5 23 20 
Hopkins et al. (23)11988 54 81 0 0 4 0 2 2.5 II 
*Use of a noasleerable dilation system: tthe majority of Ihe patients were wattally stahdized: t&r non-Q wave myocardial infarcllon. AP = angina p-eclons; 
Pls = p&n&; ref = reference number: other ahbreviarions as m Table 2. 
antithrombotic natural and pharmacologic factors leans early clot lysis occurs with or without embolization td the 
toward continued thrombus formation, persistent total cor- distal coronary bed or if an adequate collateral blood supply 
onary occlusion leading to acute myocardial infarction may is present, infarction will be limited (non-Q wave myocardiat 
occur. If the coronary artery remains occluded for a long infarction), whereas it will be extended (Q wave myocardial 
period (>I5 min), myocardial necrosis will occur. If “cry infarction) when no or late clot lysis occurs. In addition, in a 
Table 5. Reported Results of Fibrinolytic or  Anticoagulant Treatment in F’alients With 
Unstable Angina 
No of Angmgmphic Evidence of Lysis 
SwJY w-l Pts Treatment -  Pm 
Vetrovec et al. (37)  13 IC SK 77 
Mandelkom el al. (28)  9 iC SK 44 
Shapiro et al. (38)  18 IC SK 67 
Lawrence et al. (39)  
Clinical Outcome F&low-Up 
20 IV SK (24h)  + 5% Sudden death (I pt) 6mo 
coumadia 
Telford and Wilson (40)  
Gold et al. (41)  
Top01 el al. (42)  
20 Coumadm 
IIN Hepadn t atenolol 
I I4 Placebo or  arenolol 
24 IV r&PA or  placebo 
40 IV r&PA or  placebo 
WZ Sudden death (4 pts). 6mo 
Infarction (4 pts) 
3% Mycadii infarction (3 pIs) 7 days 
IS% Myourdial iafarclion (17 PIS) 7 day3 
40% Decrease in recurrem 7days 
ischemia 
Improved pacing thresh& 10 7 days 
wehernIa 
IV = intravenous; rt-PA = recombinant lissue plasminogen activalor; other abbreviations as in Table 2 and 4. 
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Table 6. Reported Angiographic Evidence of 
lnfracoronary Thrombus 
Study 
Ic Thrombua l Ime Elapsed 
-  Between Acute 
No. of No. of Event and ClilWil 
ms mr % Angiognphy Used’ 
Holmes et al. (45) I.202 16 I  3 mo ZA 
Velrovec et al. (46) 129 8 6 I  mo 2A 
Mandelkom et al. 128) 9 4 44 2 mo 3 
Capone et al. (47) II9 44 37 14 days 2A 
Capone el al. (47) 44 23 s2 24 h 2A 
2x-k et al. (48) 83 IO  I2 3 mo I .  2A. 28 
‘Definition ni intracomnary ( IC )  thrombus: I  = occlusive thrombus: 2 = 
nonocclusive lhrombus: A  = intraluminal defect: B  = inrraluminal staining: 
3 = reducrmn m severity of stenosis aner slreptokinase infusion. 
emia resulting from acute occlusion can be predicted from 
the patient’s dtagnostic angiogram, the occurrence of abrupt 
occlusion is not foreseeable. However, in the patients pre- 
sented here, there was a correlation t dtween the presence of 
intracoronary thrombus before angioplasty and the subse- 
quent development of complete coronary artery occlusion 
after attempted angioplasty. In patients with pre-existing 
intracoronary thrombus, abrupt occlusion occurred in 28% 
(12 of 43) compared with 6% (9 of 157) in those without 
angiographic evidence of intracoronary thrombus. This 
finding is consistent with other reports (7.63). and leads us to 
believe that the mechanism of occlusion in this series was an 
ongoing thrombogenic process. Coronary spasm as an alter- 
native cause of abrupt occlusion was unlikely because 
intracoronary nitroglycerin and nifedipine were routinely 
administered. In addition, the use of intensive anticoagulant 
therapy (intravenous heparht 2 to 4 days before the proce- 
dure) and routine premeditation with intravenous aspirin 
(250 mg) combined with heparin (IO.000 U) during the 
dilation did not prevent abrupt vessel occlusion from occur- 
ring either during dilation or immediately after what ap 
peared to be successful dilation. This is consistent with other 
clinical and experimental reports (7,63-65) showing !hat 
platelet thrombus deposition occurred despite continuous 
heparin use. 
Rule of thrombolytk lherapy. Because thrombolytic ther- 
apy combined with coronary angioplasty has been widely 
and safely used in the setting of acute myocardial infarction, 
we felt justified in applying this strategy in our patients with 
unstable angina who have abrupt vessel occlusion after 
angioplasty. Therefore, since 1986, the use of emergency 
redilation (with the same or an oversized balloon) or intra- 
coronary thrombolysis, or a combination of both, has been 
adopted as treatment for this complication. lntracoronary 
streptokinase was given to our patients in whom abrupt 
closure of the coronary artery immediately after dilation was 
presumably due to acute thrombosis. Of the 4 patients with 
major coronary dissection who underwent emergency sur- 
gery, 3 had myocardial infarction: in contrast, only 2 of the 
12 patients who received intracoronary ctreptokinase had 
evidence of infarction. These findings compare favorably 
with those of our previous series (3) (Table 3). suggesting 
that, in some cases, thrombolytic therapy may improve the 
immediate outcome of angioplasty in unstable angina by 
avoiding urgent surgery and procedure-related myocardial 
infarction. However, because this Has a retrospective study, 
we can only speculate about the reasons for the improve- 
ment in the result. 
Subtle but nevertheless potentially important factors that 
may have contributed to the improved results include in- 
creased operator experience, the exclusive use of better 
X-ray equipment and advanced angioplasty systems, optimi- 
zation of balloon size, longer observation period in the 
catheterization laboratory after dilation and less stringent 
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criteria for repeat dilation when the arterial segment ap- 
peared to be hazy on the angiogram. Although all of the=,e 
procedural modifications may be exerting a favorable influ- 
ence on the outcome of dilation, we believe that thrombo- 
lytic therapy itself has led to the more effective resolution of 
acute complications that occur during attempted angio- 
plasty. 
Recently reported randomized pk&ebo-cunirolled trials 
of recombinant tissue-type plasminogen activator (CPA) in 
unstable angina (41.42) further confirm the potential of 
fibrinolytic therapy in this setting. particularly in patients 
with angiographic evidence of intracoronary thrombus. 
However, Ambrose et al. (66) recently reported that intra- 
coronary streptokinase was usually ineffective in reducing 
the percent stenosis of the angina-producing vessel, mea- 
sured quantitatively, in patients with unstable angina and 
non-Q wave myorwdial inhrction. Possible explanations for 
this finding includs the possibility that there was no throm- 
bus present at the time of angiography because of spontane- 
ous lysis or hepain therapy, and that, in some patients with 
unstable angina, ‘he thrombus deposited at the site of plaque 
disruption may Jready be organized wiihin the coronary 
artery at the timI of clinical presentation (30) and, therefore, 
is resistant to short infusions of streptokinase. To achieve 
thrombolysis, it may be necessary to administer thrombo- 
lytic therapy within hours of the onset of unstable symp- 
toms. Furthermore, results of a small randomized placebo- 
controlled trial of r&PA in unstable angina (41) have shown 
that a prolonged (I2 h) infusion of &PA in combination with 
heparin effectively \vses thrombus and leads to stabilization 
of the clinical syndrome when compared with heparin alone. 
In this randomized trial, angiographic evidence of intracoro- 
nary thrombus was detected in 73% of placebo-treated 
patients but in none of the rt-PA-treated patients. A highly 
significant correlation was observed between the presence of 
thrombus and recurrent angina. However, bleeding was 
observed in 67% of the r&PA-treated patients and in none of 
the placebo-treated group. 
In our institution, thrombalysis has been used as a means 
to treat complications of angioplasty and not as a primary or 
preventive therapy. The reason for this approach is that we 
are concerned that the risk of thrombolytic agents may 
exceed the possible benefit in patients with unstable angina. 
Only 10% of the patients will develop serious complications 
with conventional therapy, and the hemorrhagic risks inher- 
ent to thrombolytic therapy with either a specific clot lysing 
agent or a systemic fibrinolytic agent are no! negligible. 
Recommendallons. Studies to date have established the 
po:ential for thrombolytic therapy to alter the course of 
unstable angina. Future studies should be directed toward 
delineating the place of thrombolytic therapy in the manage- 
ment of patients with unstable angina, especially in those 
refractory to other pharmacologic therapy. First, thrombo- 
lytic therapy could be tested as a strategy to stabilize the 
patient.5 condition. In this strategy, the thrombolytic ther- 
apy would be given early, before angiographic documenta- 
tion of the coronary anatomy. Second, it might be used as a 
preventive strategy to avoid complications during coronary 
angioplasty. With this strategy, thrombolytic therapy would 
be reserved for patients with angiographically visible thron- 
bus. Finally. it could bc used as a rescue strategy in cas: of 
abrupt vessel occlusion during attempted acgioplasty. At 
present. we are conducting a double-blind randomized trial 
of intravenous r&PA versus placebo in patients with unstable 
angina refrar!ory to pharmacologic therapy who will un- 
dergo coronary angioplasty within 24 h. 
Until firrrher informdon becomes available, we are 
using rke following practical approach. Patients with unsta- 
ble angina should initially receive prompt management, with 
stepwise intensification of pharmacologic therapy with anti- 
platelet drugs and anticoagulatioa with heparin in an attempt 
to achieve stability. Early angiographic evaluation and re- 
vascularization are indicated if this approach fails and isch- 
emit episodes continue despite maximat meaicai manage- 
ment. Coronary angioplasty is indicated when a stenosis that 
is iechnicalljy suitable for dilation is found !o be responsible 
for the unstable state. An intravenous thrombolytic agent is 
given before angioplasty in patients with angiographic evi- 
dence of intracoronary thrombus. In case of abrupt vessel 
occlusion during attempted angionlasty, intracoronary strep 
tokinase and redilation are carried out. 
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